Related references
Note: Only part of the references are listed.An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA-reactive metabolites
Reddy P. Kommaddi et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines
T. Fukasawa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Expression and function of cytochrome P450 in brain drug metabolism
R. P. Meyer et al.
CURRENT DRUG METABOLISM (2007)
Human cytochrome P450 family 4 enzymes: Function, genetic variation and regulation
Mei-Hui Hsu et al.
DRUG METABOLISM REVIEWS (2007)
Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?
Robert L. Haining et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects
Ji-Young Park et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Alprazolam as a probe for CYP3A using a single blood sample:: pharmacokinetics of parent drug, and of α- and 4-hydroxy metabolites in healthy subjects
A Wennerholm et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Estrogen regulation of the cytochrome P450 3A subfamily in humans
ET Williams et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain
SJ Chinta et al.
MOLECULAR BRAIN RESEARCH (2002)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43
A Westlind et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans
N Hirota et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2001)
Genomic organization of the human CYP3A locus:: identification of a new, inducible CYP3A gene
K Gellner et al.
PHARMACOGENETICS (2001)
Evaluation of the genetic component of variability in CYP3A4 activity:: a repeated drug administration method
V Özdemir et al.
PHARMACOGENETICS (2000)